This site is intended for Healthcare Professionals only.

Britain to trial use of Covid-19 survivors’ blood plasma for treatment

Date:

Share post:

The UK is preparing to collect the blood from Covid-19 survivors to investigate if convalescent plasma transfusions could improve an infected patient’s speed of recovery and chances of survival.

“NHS Blood and Transplant is preparing to collect Covid-19 convalescent plasma from people who have recovered from this illness,” a spokeswoman said. “We envisage that this will be initially used in trials as a possible treatment for Covid-19.”

“If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a Covid-19 patient’s speed of recovery and chances of survival,” the blood service said.

“We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible.”

People who have recovered from Covid-19 can register with the NHS if they are interested in donating plasma but they should not just turn up at blood donation centres.

(Reuters)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Pharmacy First service: Two Numark members share their experiences

Lack of cooperation from GP surgeries stalling the uptake of Pharmacy First service in some areas  The nationwide implementation...

A 5 year analysis: Rural pharmacy closures outpace openings

Findings call for more attention to rural pharmacy as only 8 opened in 2023 across the UK  The Department...

33 % rise in women seeking perinatal mental health support since 2022

One in five new and expectant mothers may be affected by perinatal mental health conditions In a significant uptick...

UK GDP Association Delivers Affordable GDP Consultancy for Small Businesses

“We want to help plug the gap where current consultancies fail these smaller businesses, and ultimately benefit UK...